» Articles » PMID: 24721975

Non-alcoholic Fatty Liver Disease, Metabolic Syndrome and Subclinical Cardiovascular Changes in the General Population

Overview
Journal Heart
Date 2014 Apr 12
PMID 24721975
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The effect of non-alcoholic fatty liver disease (NAFLD) on cardiovascular system remains controversial. We investigated the independent contribution of NAFLD to cardiovascular structure and function in the general population.

Methods: A total of 1886 participants without known cardiovascular disease were enrolled from the Korean Genome Epidemiology Study. The participants were divided into four groups, based on the presence of NAFLD, metabolic syndrome (MetS), neither or both. NAFLD was diagnosed by CT. Changes in cardiovascular structure and function were assessed by tissue Doppler imaging (TDI) echocardiography, carotid ultrasound and brachial-ankle pulse wave velocity (baPWV).

Results: In multivariate analyses, subjects with both NAFLD and MetS had a higher E/Ea ratio and baPWV, as well as a lower TDI Ea velocity (all p<0.001) than those with neither NAFLD nor MetS. Subjects with either NAFLD or MetS also showed significant differences in TDI Ea velocity and baPWV (all p<0.05). However, no significant differences of carotid intima-media thickness (CIMT) values were seen among the four groups. Multivariate linear regression revealed that both NAFLD and MetS were independent predictors of TDI Ea velocity and baPWV (all p<0.001). Both MetS and NAFLD were not a determinant of CIMT.

Conclusions: NAFLD was associated with early alterations of cardiovascular system, independent of established cardiovascular risk factors and MetS.

Citing Articles

Outcomes in Acute Decompensated Congestive Heart Failure Admissions with Chronic Liver Disease: A Nationwide Analysis Using the National Inpatient Sample.

Varughese V, Nagesh V, Moliya P, Gonzalez N, Martinez E, Mujadzic H Med Sci (Basel). 2025; 13(1).

PMID: 39982244 PMC: 11843908. DOI: 10.3390/medsci13010019.


Non-alcoholic fatty liver disease and LV diastolic dysfunction in patients with type 2 diabetes mellitus.

Faramarzpour M, Hosseiniazar M, Hooshmand Gharabagh L Caspian J Intern Med. 2024; 16(1):47-57.

PMID: 39619748 PMC: 11607126. DOI: 10.22088/cjim.16.1.47.


Effect of nano-micelle curcumin on hepatic enzymes: A new treatment approach for non-alcoholic fatty liver disease (NAFLD).

Namdar A, Ahadi M, Hoseini S, Vosoghinia H, Rajablou H, Farsi S Avicenna J Phytomed. 2023; 13(6):615-625.

PMID: 38106627 PMC: 10719728. DOI: 10.22038/AJP.2023.21919.


Non-Alcoholic Fatty Liver Disease and Echocardiographic Parameters of Left Ventricular Diastolic Function: A Systematic Review and Meta-Analysis.

Goliopoulou A, Theofilis P, Oikonomou E, Anastasiou A, Pantelidis P, Gounaridi M Int J Mol Sci. 2023; 24(18).

PMID: 37762592 PMC: 10532416. DOI: 10.3390/ijms241814292.


Association of nonalcoholic fatty liver disease and carotid media-intima thickness: A systematic review and a meta-analysis.

Khoshbaten M, Maleki S, Hadad S, Baral A, Rocha A, Poudel L Health Sci Rep. 2023; 6(9):e1554.

PMID: 37701352 PMC: 10493365. DOI: 10.1002/hsr2.1554.